Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.

[1]  R. Ross,et al.  Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). , 2011, The Canadian journal of cardiology.

[2]  Arya M. Sharma,et al.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. , 2010, The New England journal of medicine.

[3]  B. Zinman,et al.  Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study , 2010, The Lancet.

[4]  R. Ozaki,et al.  Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men. , 2010, Diabetes & metabolism.

[5]  Salim Yusuf,et al.  Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. , 2010, Journal of the American College of Cardiology.

[6]  P. Austin,et al.  Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007 , 2010, Canadian Medical Association Journal.

[7]  G. Booth,et al.  Age- and sex-related prevalence of diabetes mellitus among immigrants to Ontario, Canada , 2010, Canadian Medical Association Journal.

[8]  S. Blair,et al.  Advancing the future of physical activity guidelines in Canada: an independent expert panel interpretation of the evidence , 2010, The international journal of behavioral nutrition and physical activity.

[9]  M. Daniel,et al.  Environments and cardiometabolic diseases in aboriginal populations. , 2010, Heart, lung & circulation.

[10]  John B Buse,et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.

[11]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[12]  S. Yusuf,et al.  Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance , 2010, Diabetes Care.

[13]  M. Laakso,et al.  Effect of valsartan on the incidence of diabetes and cardiovascular events. , 2010, The New England journal of medicine.

[14]  T. Hua,et al.  Effect of nateglinide on the incidence of diabetes and cardiovascular events. , 2010, The New England journal of medicine.

[15]  Eric Boerwinkle,et al.  Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. , 2010, Journal of the American College of Cardiology.

[16]  E. A. M. Gale,et al.  The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation , 2010, Diabetologia.

[17]  Donald Lloyd-Jones,et al.  Screening for cardiovascular risk in asymptomatic patients. , 2010, Journal of the American College of Cardiology.

[18]  F. Hu,et al.  Contemporary Reviews in Cardiovascular Medicine Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk , 2010 .

[19]  Nathaniel Osgood,et al.  Epidemiology of diabetes mellitus among First Nations and non-First Nations adults , 2010, Canadian Medical Association Journal.

[20]  M. Kushel,et al.  Food insecurity is associated with chronic disease among low-income NHANES participants. , 2010, The Journal of nutrition.

[21]  Zhiqiang Wang,et al.  Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults? , 2010, Diabetes/metabolism research and reviews.

[22]  N. Wareham,et al.  The rise and fall of the metabolic syndrome , 2010, Diabetologia.

[23]  E. Ingelsson,et al.  Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men , 2010, Circulation.

[24]  Heather J. Dean,et al.  Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children , 2010, Diabetes Care.

[25]  Jean-Claude Tardif,et al.  Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. , 2009, American heart journal.

[26]  G. Tognoni,et al.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[27]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[28]  Robert Dufour,et al.  Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations , 2009 .

[29]  D. Stewart,et al.  Exploration of the Relationship Between Household Food Insecurity and Diabetes in Canada , 2009, Diabetes Care.

[30]  L. Fleisher,et al.  Cardiovascular Evaluation and Management of Severely Obese Patients Undergoing Surgery: A Science Advisory From the American Heart Association , 2009, Circulation.

[31]  M. King,et al.  Indigenous health part 1: determinants and disease patterns , 2009, The Lancet.

[32]  H. Teoh,et al.  Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations , 2009, Journal of clinical pharmacology.

[33]  R. Ross,et al.  The future of obesity reduction: beyond weight loss , 2009, Nature Reviews Endocrinology.

[34]  S. Yusuf,et al.  Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study , 2009, Heart.

[35]  P. Hansen,et al.  Determining optimal approaches for weight maintenance: a randomized controlled trial , 2009, Canadian Medical Association Journal.

[36]  B. Yawn,et al.  Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. , 2009 .

[37]  Lawrence Joseph,et al.  Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. , 2009, European heart journal.

[38]  C. Elley,et al.  Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial , 2008, BMJ : British Medical Journal.

[39]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[40]  M. Godwin,et al.  Lifestyle interventions in primary care: systematic review of randomized controlled trials. , 2008, Canadian family physician Medecin de famille canadien.

[41]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[42]  S. Harris,et al.  Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. , 2008, Diabetes research and clinical practice.

[43]  C. Apovian,et al.  American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[44]  Steven Hawken,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.

[45]  J. O'Loughlin,et al.  Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials , 2008, Canadian Medical Association Journal.

[46]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[47]  R. Ross,et al.  Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[48]  B. Zinman,et al.  Adipokines and Incident Type 2 Diabetes in a Canadian Aborigine Population , 2008, Diabetes Care.

[49]  C. Apovian,et al.  American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[50]  P. Poirier.  Healthy lifestyle: even if you are doing everything right, extra weight carries an excess risk of acute coronary events. , 2008, Circulation.

[51]  Jeffrey L. Anderson.  Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention. , 2008, The American journal of cardiology.

[52]  S. Sharp,et al.  Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? , 2008, Archives of internal medicine.

[53]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[54]  P. Pibarot,et al.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[55]  G. Fodor,et al.  Results of the Ontario Survey on the Prevalence and Control of Hypertension , 2008, Canadian Medical Association Journal.

[56]  G. Mancini,et al.  The relationship of three common definitions of the metabolic syndrome with sub-clinical carotid atherosclerosis. , 2008, Atherosclerosis.

[57]  C. Furberg,et al.  Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. , 2008, Journal of the American College of Cardiology.

[58]  J. Dixon,et al.  Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review , 2008, International Journal of Obesity.

[59]  Curt D. Furberg,et al.  Lipoprotein Management in Patients With Cardiometabolic Risk , 2008, Diabetes Care.

[60]  P. Whelton,et al.  Blood pressure and risk of cardiovascular disease in Chinese men and women. , 2008, American journal of hypertension.

[61]  J. Manson,et al.  Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. , 2008, Atherosclerosis.

[62]  R. Eckel,et al.  Cardiovascular consequences of obesity , 2008 .

[63]  S. Yusuf,et al.  Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose , 2008, Diabetes Care.

[64]  E. Ros,et al.  Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score. , 2008, Atherosclerosis.

[65]  Marc Prentki,et al.  Glycerolipid metabolism and signaling in health and disease. , 2008, Endocrine reviews.

[66]  Dana Dabelea,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[67]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[68]  P. Katzmarzyk.  Obesity and Physical Activity Among Aboriginal Canadians , 2008, Obesity.

[69]  J. Després,et al.  The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology , 2008, Annals of medicine.

[70]  S. Haffner,et al.  The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. , 2007, Annals of epidemiology.

[71]  P. Nilsson.  Cardiovascular risk in the metabolic syndrome: Fact or fiction? , 2007, Current cardiology reports.

[72]  H. Drexel,et al.  The Metabolic Syndrome and Risk of Cardiovascular Disease and Diabetes: Experiences with the New Diagnostic Criteria from the International Diabetes Federation , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[73]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[74]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[75]  R. Devereux,et al.  Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and Diabetes , 2007, Diabetes Care.

[76]  C. Barbagallo,et al.  The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. , 2007, Atherosclerosis.

[77]  M. Simoons,et al.  Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial , 2007, Heart.

[78]  Y. Ohashi,et al.  Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. , 2007, Archives of internal medicine.

[79]  B. Hedblad,et al.  The metabolic syndrome and incidence of cardiovascular disease in non‐diabetic subjects—a population‐based study comparing three different definitions , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[80]  R. Ross,et al.  Physical activity in the treatment of obesity: beyond body weight reduction. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[81]  Vladimir Vuksan,et al.  Defining Obesity Cut Points in a Multiethnic Population , 2007, Circulation.

[82]  J. Douketis,et al.  2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] , 2007, Canadian Medical Association Journal.

[83]  S. Verma,et al.  Adiponectin and cardiovascular disease: state of the art? , 2007, American journal of physiology. Heart and circulatory physiology.

[84]  M. Laakso,et al.  The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. , 2007, European heart journal.

[85]  K. Clément,et al.  Acute Hyperglycemia Induces a Global Downregulation of Gene Expression in Adipose Tissue and Skeletal Muscle of Healthy Subjects , 2007, Diabetes.

[86]  Y. Friedlander,et al.  Does a diagnosis of the metabolic syndrome provide additional prediction of cardiovascular disease and total mortality in the elderly? The Dubbo Study , 2007, The Medical journal of Australia.

[87]  G. Bakris.  Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome , 2007, Diabetes Care.

[88]  G. Bray,et al.  Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.

[89]  S. S. Tai,et al.  Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. , 2007, Health technology assessment.

[90]  C. Day.  Metabolic syndrome, or What you will: definitions and epidemiology , 2007, Diabetes & vascular disease research.

[91]  G. Can,et al.  Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation , 2007, International Journal of Obesity.

[92]  Allen J. Taylor,et al.  The Framingham Risk Score: an appraisal of its benefits and limitations. , 2007, The American heart hospital journal.

[93]  J. Liao.  Safety and efficacy of statins in Asians. , 2007, The American journal of cardiology.

[94]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[95]  K. Tucker,et al.  Nutritional strategies in the prevention and treatment of metabolic syndrome. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[96]  F. Conus,et al.  Characteristics of metabolically obese normal-weight (MONW) subjects. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[97]  S. Yusuf,et al.  Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. , 2007, JAMA.

[98]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[99]  M. King,et al.  High rates of the metabolic syndrome in a First Nations Community in western Canada: prevalence and determinants in adults and children. , 2006, International journal of circumpolar health.

[100]  N. Chaturvedi,et al.  Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population , 2006, Canadian Medical Association Journal.

[101]  Deborah F Tate,et al.  A self-regulation program for maintenance of weight loss. , 2006, The New England journal of medicine.

[102]  Jiang He,et al.  Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. , 2006, The American journal of medicine.

[103]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[104]  J. Stein,et al.  Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[105]  S. Yusuf,et al.  Social disadvantage and cardiovascular disease: development of an index and analysis of age, sex, and ethnicity effects. , 2006, International journal of epidemiology.

[106]  S. Yusuf,et al.  Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials , 2006, The Lancet.

[107]  N. Sattar.  The metabolic syndrome: should current criteria influence clinical practice? , 2006, Current Opinion in Lipidology.

[108]  J. Wylie-Rosett,et al.  Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.

[109]  S. Daskalopoulou,et al.  Definitions of metabolic syndrome: Where are we now? , 2006, Current vascular pharmacology.

[110]  R. Eckel,et al.  Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.

[111]  S. Verma,et al.  South Asians and cardiovascular risk: what clinicians should know. , 2006, Circulation.

[112]  P. Neufer,et al.  Exercise and Improved Insulin Sensitivity in Older Women: Evidence of the Enduring Benefits of Higher Intensity Training. , 2006, Journal of applied physiology.

[113]  E. Ravussin,et al.  Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. , 2006, Diabetes care.

[114]  I. Anderson,et al.  Indigenous health in Australia, New Zealand, and the Pacific , 2006, The Lancet.

[115]  P. McBride,et al.  Ultrasound-detected carotid plaque as a predictor of cardiovascular events , 2006, Vascular medicine.

[116]  J. Després,et al.  Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk , 2006 .

[117]  S. Oparil,et al.  Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.

[118]  Paul M Ridker,et al.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.

[119]  T Fahey,et al.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review , 2006, Heart.

[120]  B. Zinman,et al.  Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada , 2006, International Journal of Obesity.

[121]  S. Brister,et al.  Is South Asian ethnicity an independent cardiovascular risk factor? , 2006, The Canadian journal of cardiology.

[122]  Ralph B D'Agostino,et al.  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.

[123]  S. Haffner,et al.  The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. , 2006, The American journal of cardiology.

[124]  D. Herrington,et al.  Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[125]  R. Burger,et al.  Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study , 2005, BMJ : British Medical Journal.

[126]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[127]  P Glasziou,et al.  Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.

[128]  L. Lind,et al.  The Apolipoprotein B/AI Ratio and the Metabolic Syndrome Independently Predict Risk for Myocardial Infarction in Middle-Aged Men , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[129]  R. Fagard.  Effects of exercise, diet and their combination on blood pressure , 2005, Journal of Human Hypertension.

[130]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[131]  B. Zinman,et al.  Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths , 2005, Canadian Medical Association Journal.

[132]  Véronique A. Cornelissen,et al.  Effects of Endurance Training on Blood Pressure, Blood Pressure–Regulating Mechanisms, and Cardiovascular Risk Factors , 2005, Hypertension.

[133]  M. Caulfield,et al.  Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) , 2005, The Lancet.

[134]  Irwin Feuerstein,et al.  Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. , 2005, Journal of the American College of Cardiology.

[135]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[136]  R. Kahn,et al.  The metabolic syndrome: time for a critical appraisal , 2005, Diabetologia.

[137]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[138]  D. Lau,et al.  Adipokines: molecular links between obesity and atheroslcerosis. , 2005, American journal of physiology. Heart and circulatory physiology.

[139]  C. McCulloch,et al.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. , 2005, Archives of internal medicine.

[140]  S. Fowler,et al.  The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.

[141]  R. Vettor,et al.  Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies. , 2005, Diabetes care.

[142]  J. Després,et al.  Impact of Waist Circumference on the Relationship Between Blood Pressure and Insulin: The Quebec Health Survey , 2005, Hypertension.

[143]  J. Griffith,et al.  Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. , 2005, JAMA.

[144]  Claude Bouchard,et al.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.

[145]  J. Concato,et al.  Two measures of insulin sensitivity provided similar information in a U.S. population. , 2004, Journal of clinical epidemiology.

[146]  N. Nguyen,et al.  The Relationship Between Hospital Volume and Outcome in Bariatric Surgery at Academic Medical Centers , 2004, Annals of surgery.

[147]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[148]  Steven B Heymsfield,et al.  Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. , 2004, Diabetes care.

[149]  R. Petrella,et al.  Lifestyle management for type 2 diabetes. Are family physicians ready and willing? , 2004, Canadian family physician Medecin de famille canadien.

[150]  C. Bouchard,et al.  The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study. , 2004, Metabolism: clinical and experimental.

[151]  S. Yusuf,et al.  C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[152]  C. Ballantyne,et al.  Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. , 2004, The Journal of clinical endocrinology and metabolism.

[153]  R. Ross,et al.  Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. , 2004, Obesity research.

[154]  G. Reboldi,et al.  Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects , 2004, Hypertension.

[155]  H. Drexel,et al.  Lp(a) lipoprotein, vascular disease, and mortality in the elderly. , 2004 .

[156]  S. Grundy,et al.  Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[157]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[158]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[159]  Jaakko Tuomilehto,et al.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.

[160]  R. Petrella,et al.  Lifestyle interventions for type 2 diabetes. Relevance for clinical practice. , 2003, Canadian family physician Medecin de famille canadien.

[161]  A. Ariyo,et al.  Lp(a) lipoprotein, vascular disease, and mortality in the elderly. , 2003, The New England journal of medicine.

[162]  Diederick E. Grobbee,et al.  Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.

[163]  Karen C Johnson,et al.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. , 2003, Controlled clinical trials.

[164]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[165]  J. Blanchard,et al.  The epidemiology of diabetes in the Manitoba-registered First Nation population: current patterns and comparative trends. , 2003, Diabetes care.

[166]  Sophie Rome,et al.  Microarray Profiling of Human Skeletal Muscle Reveals That Insulin Regulates ∼800 Genes during a Hyperinsulinemic Clamp* 210 , 2003, The Journal of Biological Chemistry.

[167]  S. Teutsch,et al.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. , 2003, Diabetes.

[168]  James W. Anderson,et al.  Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies , 2003, Journal of the American College of Nutrition.

[169]  R. Collins,et al.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.

[170]  John D Potter,et al.  Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. , 2003, JAMA.

[171]  S. Grundy,et al.  Diet composition and the metabolic syndrome: what is the optimal fat intake? , 2002, The American journal of medicine.

[172]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[173]  W. Kraus,et al.  Effects of the amount and intensity of exercise on plasma lipoproteins. , 2002, The New England journal of medicine.

[174]  P. Deurenberg,et al.  Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[175]  S. Goodwin,et al.  The Practical Guide to the Identification, Evaluation and Treatment of Overweight and Obesity in Adults , 2002 .

[176]  Jiang He,et al.  Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.

[177]  S. Yusuf,et al.  Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[178]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[179]  B. Zinman,et al.  The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. , 2002, Diabetes research and clinical practice.

[180]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[181]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[182]  R. Peto,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[183]  M. Brownlee.  Insight Review Articles , 2022 .

[184]  S. Yusuf,et al.  Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP) , 2001, The Lancet.

[185]  P. Deurenberg,et al.  Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore , 2001, International Journal of Obesity.

[186]  R. Marfella,et al.  Acute hyperglycemia induces an oxidative stress in healthy subjects. , 2001, The Journal of clinical investigation.

[187]  R. Ross,et al.  Physical activity, total and regional obesity: dose-response considerations. , 2001, Medicine and science in sports and exercise.

[188]  A. Leon,et al.  Response of blood lipids to exercise training alone or combined with dietary intervention. , 2001, Medicine and science in sports and exercise.

[189]  P. Thompson,et al.  The acute versus the chronic response to exercise. , 2001, Medicine and science in sports and exercise.

[190]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[191]  O. Ljungqvist,et al.  AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. , 2001, Diabetes.

[192]  A. Kung,et al.  Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese , 2001, International Journal of Obesity.

[193]  J. Després,et al.  Treatment of obesity: need to focus on high risk abdominally obese patients , 2001, BMJ : British Medical Journal.

[194]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[195]  H. Utsumi,et al.  High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.

[196]  G. Bakris,et al.  ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. , 2000, Kidney international.

[197]  Michael D. Brown,et al.  The Role of Exercise Training in the Treatment of Hypertension , 2000, Sports medicine.

[198]  L. Niskanen,et al.  Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. , 2000, Medicine and science in sports and exercise.

[199]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[200]  Robert Ross,et al.  Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men , 2000, Annals of Internal Medicine.

[201]  Bezafibrate Infarction Prevention study.  Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. , 2000, Circulation.

[202]  P. Grant,et al.  Plasminogen-activator inhibitor type 1 and coronary artery disease. , 2000, The New England journal of medicine.

[203]  G. Riccardi,et al.  Dietary treatment of the metabolic syndrome — the optimal diet , 2000, British Journal of Nutrition.

[204]  G. Bakris,et al.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.

[205]  R. Schwartz,et al.  Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. , 2000, The Journal of clinical endocrinology and metabolism.

[206]  J. Woo,et al.  Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese , 1999, International Journal of Obesity.

[207]  R. Fagard.  Physical activity in the prevention and treatment of hypertension in the obese. , 1999, Medicine and science in sports and exercise.

[208]  M. Stefanick.  Physical activity for preventing and treating obesity-related dyslipoproteinemias. , 1999, Medicine and science in sports and exercise.

[209]  T. Wilt,et al.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.

[210]  S. Yusuf,et al.  Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[211]  R. Withers,et al.  Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: A meta-analysis of randomized, controlled trials , 1999, European Journal of Clinical Nutrition.

[212]  J. Wang,et al.  The impact of body build on the relationship between body mass index and percent body fat , 1999, International Journal of Obesity.

[213]  R R Wing,et al.  Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. , 1999, Diabetes.

[214]  G. Kelley.  Aerobic exercise and resting blood pressure among women: a meta-analysis. , 1999, Preventive medicine.

[215]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[216]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[217]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[218]  R N Bergman,et al.  Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. , 1998, JAMA.

[219]  A. Baron,et al.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.

[220]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[221]  M. Kjaer,et al.  The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients , 1997, Diabetologia.

[222]  A. Avenell,et al.  Waist circumference reduction and cardiovascular benefits during weight loss in women , 1997, International Journal of Obesity.

[223]  B. Zinman,et al.  The Prevalence of NIDDM and Associated Risk Factors in Native Canadians , 1997, Diabetes Care.

[224]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[225]  J. Mehta,et al.  Meeting of the International Working Group on Coronary Artery Disease in South Asians. 24 March 1996, Orlando, Florida, USA. , 1996, Indian heart journal.

[226]  D L Rothman,et al.  Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.

[227]  N. Cook,et al.  Implications of small reductions in diastolic blood pressure for primary prevention. , 1995, Archives of internal medicine.

[228]  R. Wing,et al.  Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.

[229]  C. van Weel,et al.  Diabetes and its long-term complications in general practice: a survey in a well-defined population. , 1993, Family practice.

[230]  A. Sönnichsen,et al.  Benefit from hypocaloric diet in obese men depends on the extent of weight-loss regarding cholesterol, and on a simultaneous change in body fat distribution regarding insulin sensitivity and glucose tolerance. , 1992, Metabolism: clinical and experimental.

[231]  A M Dattilo,et al.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. , 1992, The American journal of clinical nutrition.

[232]  R. Beaglehole,et al.  Does physical activity lower blood pressure: a critical review of the clinical trials. , 1992, Journal of clinical epidemiology.

[233]  P. Wilson,et al.  The epidemiology of impaired glucose tolerance and hypertension. , 1991, American heart journal.

[234]  Y. Epstein,et al.  Effect of an acute bout of exercise on glucose disposal in human obesity. , 1990, Journal of applied physiology.

[235]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[236]  H. Galbo,et al.  Effect of physical exercise on sensitivity and responsiveness to insulin in humans. , 1988, The American journal of physiology.

[237]  E. Horton,et al.  Enhanced Peripheral and Splanchnic Insulin Sensitivity in NIDDM Men After Single Bout of Exercise , 1987, Diabetes.

[238]  P. Nilsson-ehle,et al.  Plasma lipoproteins and lipolytic enzyme activities during endurance training in sedentary men: changes in high-density lipoprotein subfractions and composition. , 1983, Metabolism: clinical and experimental.

[239]  D. Ballantyne,et al.  The Effect of Moderate Physical Exercise on the Plasma Lipoprotein Subfractions of Male Survivors of Myocardial Infarction , 1982, Circulation.

[240]  M. Maxwell,et al.  Clinical characteristics of renovascular hypertension. , 1972, JAMA.

[241]  S. Mudaliar,et al.  Actos Now for the prevention of diabetes (ACT NOW) study , 2009, BMC endocrine disorders.

[242]  B. Zinman,et al.  Comparison of the clinical management of type 2 diabetes in Canada's First Nations peoples to national guidelines: the CIRCLE study , 2009 .

[243]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[244]  J. Després,et al.  Visceral obesity and the heart. , 2008, The international journal of biochemistry & cell biology.

[245]  E. Lonn,et al.  Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population. , 2008, Atherosclerosis.

[246]  S. Verma,et al.  Ethnic diversity: South Asian ethnicity is associated with increased coronary artery bypass grafting mortality. , 2007, The Journal of thoracic and cardiovascular surgery.

[247]  Patricia J. Martens,et al.  Diabetes and Adverse Outcomes in a First Nations Population: Associations With Healthcare Access, and Socioeconomic and Geographical Factors , 2007 .

[248]  B. Drolet,et al.  Impact of Weight-Loss Medications on the Cardiovascular System , 2007, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[249]  R. McKelvie,et al.  Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. , 2006, The Canadian journal of cardiology.

[250]  Narendra Singh,et al.  Clinical characteristics of South Asian patients hospitalized with heart failure. , 2005, Ethnicity & disease.

[251]  D. Lawlor,et al.  Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study , 2005, Diabetologia.

[252]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[253]  Wen-Harn Pan,et al.  Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. , 2004, The American journal of clinical nutrition.

[254]  S. Carroll,et al.  What is the Relationship Between Exercise and Metabolic Abnormalities? , 2004, Sports medicine.

[255]  V. Burke,et al.  The independent and combined effects of 16 weeks of vigorous exercise and energy restriction on body mass and composition in free-living overweight men--a randomized controlled trial. , 2003, Metabolism: clinical and experimental.

[256]  S. Teutsch,et al.  THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES III); NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP). NCEP-DEFI NED METABOLIC SYNDROME, DIABETES, AND PREVALENCE OF CORONARY HEART DISEASE AMONG NHANES III PARTICIPANTS AGE 50 YEARS AND OLDER , 2003 .

[257]  K. DuBose,et al.  Blood Lipid and Lipoprotein Adaptations to Exercise , 2001, Sports medicine.

[258]  S. Taimela,et al.  Exercise and the metabolic syndrome , 1997, Diabetologia.

[259]  Kelley Ga.  Effects of aerobic exercise in normotensive adults: a brief meta-analytic review of controlled clinical trials. , 1995 .